BioAdvance News Portfolio News Renovacor

Renovacor Announces the Appointment of Marc Semigran, M.D., as Chief Medical Officer

By WebmasterJune 2, 2021November 1st, 2024No Comments

Renovacor Announces the Appointment of Marc Semigran, M.D., as Chief Medical Officer

Former chief medical officer of MyoKardia to lead clinical development at Renovacor

Previous PostMelior Pharmaceuticals Announces Entry Into “Letter-of-Intent” for the Acquisition of Armesocarb by Adhera Therapeutics
Next PostAnnovis Bio, Inc. Announces Closing of $50 Million Public Offering